New drug tested to fight anemia in dialysis patients
NCT ID NCT03461146
Summary
This study tested a drug called MT-6548 for people on kidney dialysis who have anemia (low red blood cells). The goal was to see if the drug could safely raise and keep hemoglobin levels in a healthy range. It involved 24 participants in Japan who were not using other common anemia medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Aichi, Japan
-
Research site
Chiba, Japan
-
Research site
Fukushima, Japan
-
Research site
Gunma, Japan
-
Research site
Hokkaido, Japan
-
Research site
Hyōgo, Japan
-
Research site
Ibaraki, Japan
-
Research site
Kagoshima, Japan
-
Research site
Nagano, Japan
-
Research site
Okayama, Japan
-
Research site
Okinawa, Japan
-
Research site
Osaka, Japan
-
Research site
Saitama, Japan
-
Research site
Shiga, Japan
-
Research site
Shizuoka, Japan
-
Research site
Yamagata, Japan
Conditions
Explore the condition pages connected to this study.